EUVIMEDEUVIMED entdecken
Crossref

Hepatic stellate cells shape the ECM-disorganized and immunosuppressive microenvironment via CCL11/CCR3 axis in lenvatinib-treated hepatocellular carcinoma

Na Qiang, Cheng Lan, An Lin, Hiroaki Kanzaki, Masanori Inoue, Naoya Kanogawa, Takayuki Kondo, Sadahisa Ogasawara, Masato Nakamura, Shingo Nakamoto, Dawei Cui, Hang Lv und 3 weitere

Cellular Signalling · 2026-02 · 138 · 112263

DOI: 10.1016/j.cellsig.2025.112263 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2026-02. Verfasst von Na Qiang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Receptors, CCR3, Liver Neoplasms, Quinolines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Guangzhou Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatic stellate cell (HSC) activation plays a crucial role in the progression from chronic liver disease to hepatocellular carcinoma (HCC) by establishing disorganized extracellular matrix (ECM) and facilitating immune evasion. However, the effects of HSC on the tumor microenvironment (TME) in lenvatinib (LEN)-treated HCC have not been well explored. In the present study, CCL11 secretory levels elevated in both the serum of HCC patients and the supernatant of HSCs following LEN treatment. In HSCs, CCL11 protein increased, while a CCR3 inhibitor decreased, expression of CCL11- and ECM-related genes: Col3a1 and Col16a1. Based on the expression of Ccl11 and its top 10 related genes, TCGA HCC samples (n = 371) were stratified into high- (n = 175) and low-expression (n = 196) groups. The pathways related to ECM and cell chemotaxis were upregulated in the high-expression group through GO and KEGG analyses. Tumor-associated- macrophages (TAMs) and neutrophils (TANs) and their marker genes (Cd206 and S100a9) were also enriched in this group. Mechanically, the over-production of CCL11 activates HSCs through the CCL11/CCR3 signaling pathway, resulting in the augmented CCL26 secretion to promote the infiltration of TAMs and TANs. In mice, LEN showed weaker tumor control and increased COL3A1, CD206, and S100A9 expression in tumors co-transplanted with HSCs versus tumor cells alone. Combining a CCR3 inhibitor with LEN reversed these effects. In conclusion, CCL11 over-production drives HSC activation, creating an ECM-disorganized and immunosuppressive TME via the CCL11/CCR3 axis in LEN-treated HCC. Combination therapy with CCR3 inhibitor and LEN might represent a novel therapeutic strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularReceptors, CCR3Liver NeoplasmsQuinolinesHepatic Stellate CellsTumor MicroenvironmentPhenylurea CompoundsExtracellular MatrixChemokine CCL11AnimalsHumansMiceMaleCell Line, TumorFemale

Stichwörter der Autor:innen

CCL11Extracellular matrixHepatic stellate cellsHepatocellular carcinomaImmunosuppressionLenvatinib

Substanzen

Receptors, CCR3QuinolineslenvatinibPhenylurea CompoundsChemokine CCL11CCR3 protein, human

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China.
  • Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Gastroenterology, Graduate School of Medicine, Chiba University,…
  • Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Biospecimen Repository, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.
  • Zhejiang Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China. Electronic addr…

Förderung

  • Guangzhou Medical University

Zitieren

APA

Qiang, N., Lan, C., Lin, A., Kanzaki, H., Inoue, M., Kanogawa, N., Kondo, T., Ogasawara, S., Nakamura, M., Nakamoto, S., Cui, D., Lv, H., Xu, Q., Chen, G., & Ao, J. (2026). Hepatic stellate cells shape the ECM-disorganized and immunosuppressive microenvironment via CCL11/CCR3 axis in lenvatinib-treated hepatocellular carcinoma. Cellular Signalling, 138, 112263. https://doi.org/10.1016/j.cellsig.2025.112263

Vancouver

Qiang N, Lan C, Lin A, Kanzaki H, Inoue M, Kanogawa N, et al. Hepatic stellate cells shape the ECM-disorganized and immunosuppressive microenvironment via CCL11/CCR3 axis in lenvatinib-treated hepatocellular carcinoma. Cellular Signalling. 2026;138:112263. doi:10.1016/j.cellsig.2025.112263

BibTeX
@article{Qiang2026,
  author = {Qiang, Na and Lan, Cheng and Lin, An and Kanzaki, Hiroaki and Inoue, Masanori and Kanogawa, Naoya and Kondo, Takayuki and Ogasawara, Sadahisa and Nakamura, Masato and Nakamoto, Shingo and Cui, Dawei and Lv, Hang and Xu, Qiuran and Chen, Guiping and Ao, Junjie},
  title = {Hepatic stellate cells shape the ECM-disorganized and immunosuppressive microenvironment via CCL11/CCR3 axis in lenvatinib-treated hepatocellular carcinoma},
  journal = {Cellular Signalling},
  year = {2026},
  volume = {138},
  pages = {112263},
  doi = {10.1016/j.cellsig.2025.112263}
}
Kostenlos starten →